A Phase I Study of BMS-986015 with Ipilimumab in Patients with Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Melanoma
[Protocol 12-283] |
Rizvi, Naiyer |
- Lung Cancer, Non-Small Cell
- Melanoma
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
- Solid Tumors
|
A Phase I Study of Humanized 3F8 plus Interleukin-2 in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
[Protocol 12-116] |
Roberts, Stephen |
- Neuroblastoma
- Sarcomas
- Osteosarcoma
- Soft Tissue Sarcoma
|
A Phase II Study of Veliparib plus Temozolomide, Veliparib plus Carboplatin and Paclitaxel, or Carboplatin and Paclitaxel with Placebo in Patients with BRCA Mutations and Metastatic Breast Cancer
[Protocol 12-122] |
Robson, Mark |
|
Understanding Decision-Making Processes for Undergoing Genetic Testing Among Women with Newly Diagnosed Breast Cancer
[Protocol 11-086] |
Robson, Mark |
- Breast Cancer
- Hereditary Cancer & Genetics
|
Use of High-Resolution Structural MRI to Assess Changes in Brain Structure Related to Chemotherapy in Patients with Non-Small Cell Lung Cancer: A Prospective Study
[Protocol 11-145] |
Root, James |
- Lung Cancer
- Lung Cancer, Non-Small Cell
- Survivorship
|
A Phase III Study of Gemcitabine and Cisplatin with and without Bevacizumab in Patients with Advanced Transitional Cell Carcinoma
[Protocol 12-119] |
Rosenberg, Jonathan |
- Bladder Cancer
- Kidney Cancer
|
A Pilot Study of a Geriatric-Specific Psychoeducational Intervention for Elderly Cancer Patients
[Protocol 09-116] |
Roth, Andrew |
- Breast Cancer
- Geriatrics
- Prostate Cancer
- Localized Disease
- Quality of Life
|
A Phase I Study of GL-ONC1 for Treating Malignant Pleural Effusion
[Protocol 12-169] |
Rusch, Valerie |
- Breast Cancer
- Lung Cancer
- Lung Cancer, Non-Small Cell
- Lung Cancer, Small Cell
- Mesothelioma
|
A Phase I Trial of a New Vaccine (Globo-H-GM2-sTn-TF-Tn) for Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
[Protocol 09-184] |
Sabbatini, Paul |
|
Chemotherapy Alone or with Radiation Therapy for Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery
[Protocol 12-087] |
Saltz, Leonard |
|
Quality of Life Outcomes Following Minimally Invasive versus Open Esophagectomy for Esophageal Cancer
[Protocol 12-003] |
Sarkaria, Inderpal |
|
A Study of Allogeneic Stem Cell Transplantation in HIV-Infected Patients with Hematologic Cancers
[Protocol 12-092] |
Sauter, Craig |
- Blood and Marrow Transplantation
- Hematology
- Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
|
A Phase I Study of High-Dose Therapy and Autologous Stem Cell Transplantation Followed by Modified T Cells for Aggressive B-Cell Non-Hodgkin Lymphoma
[Protocol 12-117] |
Sauter, Craig |
|
A Phase III Study of Cabozantinib (XL184) versus Mitoxantrone/Prednisone in Men with Previously Treated Symptomatic Castration-Resistant Prostate Cancer
[Protocol 12-032] |
Scher, Howard |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
- Quality of Life
|
A Phase II Study of Abiraterone, Prednisone, and Degarelix in Men with Recurrent Prostate Cancer and a Rising PSA
[Protocol 12-187] |
Scher, Howard |
- Prostate Cancer
- Rising PSA After Primary Therapy
|
A Phase I Study of AEB071 in Patients with Metastatic Uveal Melanoma
[Protocol 11-167] |
Schwartz, Gary |
|
A Phase I Study of BMS-663513 (Anti-CD137 Antibody) in Patients with Advanced or Metastatic Solid Tumors
[Protocol 11-212] |
Segal, Neil |
|
A Phase I Study of PF-05082566 Alone in Patients with Advanced Cancer, and in Combination with Rituximab in Patients with Non-Hodgkin Lymphoma
[Protocol 11-085] |
Segal, Neil |
|
A Phase I Study of MED14736 in Patients with Advanced Solid Tumors
[Protocol 12-179] |
Segal, Neil |
|
A Phase I Study of BMS-986015 plus BMS-936558 in Patients with Advanced Solid Tumors
[Protocol 12-224] |
Segal, Neil |
- Colorectal Cancer
- Kidney Cancer
- Lung Cancer, Non-Small Cell
- Melanoma
- Ovarian Cancer
|
